Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$2.5 - $3.42 $149,300 - $204,242
59,720 New
59,720 $186,000
Q3 2021

Nov 12, 2021

SELL
$7.04 - $10.49 $126,720 - $188,820
-18,000 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$6.08 - $10.44 $109,440 - $187,920
18,000 New
18,000 $177,000

Others Institutions Holding GRTX

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $2.15M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.